NEW YORK — When the SARS-CoV-2 virus emerged in late 2019, the global scientific community held a crucial, albeit narrow, advantage. Decades of prior, painstaking academic research on coronaviruses meant researchers already possessed a foundational understanding of the pathogen’s key proteins. This pre-existing structural knowledge enabled vaccine developers to design life-saving inoculations in record-breaking time. […]

